ICAM1 and diabetic kidney disease: They showed that miR-146a/NAPDH oxidase4 pathway inhibits overproduction of ROS, oxidative stress and inflammation, and suppresses the protein expression of VCAM 1 and ICAM 1 in mice with diabetic nephropathy (17).